Most companies overlook a massive opportunity in early diagnosis for cardiovascular disease, and the stakes couldn’t be higher.

On this episode of The Long Game, Ross and Sandy reveal how Scotland’s thriving biotech ecosystem is turning understanding of the “broken heart” into ground breaking tech that could save lives and billions in healthcare costs.

Right now, Scotland faces an alarming crisis: a stunning one-third of all deaths are caused by heart disease, stroke, and related vascular conditions, and it hits women twice as hard as breast cancer. Despite common myths, heart disease is not just an "old man's disease"—it’s the leading killer of women too, and it often goes unnoticed until it's too late. You’ll discover compelling data that shatters misconceptions, showing how genetics, lifestyle, and stark health inequalities combine to make cardiovascular disease Scotland’s #1 health burden.

We break down how early diagnostics, innovative imaging techniques, and leveraging Scotland’s rich health data can tip the balance. You'll learn about the Scottish initiatives that use AI and predictive analytics to catch heart issues before they become catastrophic. Plus, Sandy shares how the Scottish biotech scene is poised to turn these insights into impactful startups, and the crucial role entrepreneurs can play in driving structural cost savings for the NHS.

Missing this opportunity means accepting inevitability and delaying action that could save lives and billions. Meanwhile, detailed research and tech innovation promise a future where early detection is standard, and preventable deaths drop significantly. This isn’t just science; it’s an economic game-changer for Scotland and beyond.